<DOC>
	<DOCNO>NCT02962440</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate absorption , metabolism excretion somapacitan single subcutaneous dose healthy male subject .</brief_summary>
	<brief_title>A Trial Investigating Absorption , Metabolism Excretion Somapacitan After Single Dosing Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>Male , age 4564 year ( inclusive ) time sign informed consent Body mass index ( BMI ) 20.029.9 kg/m^2 ( inclusive ) Considered generally healthy base medical history , physical examination , result vital sign , electrocardiogram clinical laboratory test perform screen visit , judge investigator Male reproductive age whose partner ( ) willing use adequate contraceptive method ( adequate contraceptive measure require local regulation practice ) least 4 month dose male willing refrain donate semen least 4 month dose . Acceptable form prevention include complete sexual abstinence , surgically sterilisation , subject us condom intercourse partner practice adequate contraception ( risk pregnancy must lower 1 % ) . Use prescription nonprescription product , include herbal product nonroutine vitamin , within 14 day prior screen . Occasional use paracetamol permit . Any blood draw excess 25 mL past 30 day , donation blood plasma excess 400 mL within 90 day precede screening .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>